source
- Mass General Brigham drops Dana-Farber from its Medicare Advantage network starting Oct 1Mass General Brigham announced that its Medicare Advantage plan will no longer include Dana-Farber Cancer Institute in its provider network beginning October 1, following a recent split between the…
- FDA revisits botanical drug pathway amid ongoing challenges for clozapine and pig kidney researchThe Food and Drug Administration is taking another look at the regulatory pathway for botanical drugs, signaling renewed interest in how plant‑derived therapies can be evaluated and approved. At t…